Loading
Total declarations
Companies
▲ Purchases (5 ops.)
▼ Sales (0 ops.)
Latest filing published 08 Jul 2026 for Evommune, Inc., €116k.
Filing timeline
BuySaleArthur S. Kirsch
Insider track record
Disclosed buys
5
Disclosed sells
0
Signal history
Closed purchases
Market purchases
5
Positive at T+90
50%
Median T+90
-14.3%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -61.0%Entry US$13.51 · Close 19 Oct 2026 US$5.27
- +1.2%Entry US$4.86 · Close at T+365 US$4.92
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Arthur S. Kirsch: trading record in brief
Arthur S. Kirsch is a declared insider at 6 companies (board member); the most frequent names are Liquidia Corp, Liquidia Technologies Inc and Aralez Pharmaceuticals Inc. In total, 12 filings cover trades dated from 20 January 2016 to 7 July 2026.
On the market, this insider has only ever bought: 5 purchases, €258k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 3 share grants and 2 option exercises. So far in 2026, the count stands at 1 purchase and no sales.
In size, the median ticket on the buying side is €16k.
On 8 July 2026 came the latest disclosure, an open-market purchase for €116k in Evommune, Inc. Typically, a trade is published a median of 3 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Arthur S. Kirsch
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations12 total
10,000 shares@ US$13.300.041% mcap100.0% of flowCommon StockSEC:0001290976-26-000004:0
Canonical exit: 5 Oct 2026 (T+90)
18,396 shares0Common StockSEC:0001104659-25-061190:0
20,359 shares0Common StockSEC:0001104659-24-074472:0
30,000 shares@ US$4.24100.0% of flowCommon StockSEC:0001104659-21-138087:0
Canonical exit: 8 Feb 2022 (T+90)
30,000 shares@ US$9.5080.6% of flowCommon StockSEC:0001104659-21-136408:0
20,000 shares@ US$3.5819.4% of flowCommon stockSEC:0001593968-21-001331:0
105 shares@ US$18.00Common StockSEC:0001104659-18-068771:0
Canonical exit: 11 Feb 2019 (T+90)
895 shares@ US$18.50Common StockSEC:0001104659-18-068771:1
Canonical exit: 12 Feb 2019 (T+90)
1,000 shares@ US$18.25Common StockSEC:0001104659-18-067907:0
Canonical exit: 6 Feb 2019 (T+90)
64,719 sharesCommon SharesSEC:0001104659-16-095173:0
6,107 sharesCommon StockSEC:0001104659-16-094738:0
6,107 sharesCommon StockSEC:0001104659-16-091019:0
12 of 12 declarations
